These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34550870)

  • 1. A Novel Protective Role for Matrix Metalloproteinase-8 in the Pulmonary Vasculature.
    Dieffenbach PB; Mallarino Haeger C; Rehman R; Corcoran AM; Coronata AMF; Vellarikkal SK; Chrobak I; Waxman AB; Vitali SH; Sholl LM; Padera RF; Lagares D; Polverino F; Owen CA; Fredenburgh LE
    Am J Respir Crit Care Med; 2021 Dec; 204(12):1433-1451. PubMed ID: 34550870
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-canonical IKB kinases regulate YAP/TAZ and pathological vascular remodeling behaviors in pulmonary artery smooth muscle cells.
    Aravamudhan A; Dieffenbach PB; Choi KM; Link PA; Meridew JA; Haak AJ; Fredenburgh LE; Tschumperlin DJ
    Physiol Rep; 2024 Apr; 12(7):e15999. PubMed ID: 38610069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial stiffness induces remodeling phenotypes in pulmonary artery smooth muscle cells via YAP/TAZ-mediated repression of cyclooxygenase-2.
    Dieffenbach PB; Haeger CM; Coronata AMF; Choi KM; Varelas X; Tschumperlin DJ; Fredenburgh LE
    Am J Physiol Lung Cell Mol Physiol; 2017 Sep; 313(3):L628-L647. PubMed ID: 28642262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGB2 Release Promotes Pulmonary Hypertension and Predicts Severity and Mortality of Patients With Pulmonary Arterial Hypertension.
    Kong D; Liu J; Lu J; Zeng C; Chen H; Duan Z; Yu K; Zheng X; Zou P; Zhou L; Lv Y; Zeng Q; Lu L; Li J; He Y
    Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):e172-e195. PubMed ID: 38572649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2-YAP signaling is implicated in pulmonary arterial hypertension development.
    Ye P; Deng Y; Gu Y; Liu P; Luo J; Pu J; Chen J; Huang Y; Wang N; Ji Y; Chen S
    Chin Med J (Engl); 2024 Apr; 137(7):846-858. PubMed ID: 38242702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAMTS8 Promotes the Development of Pulmonary Arterial Hypertension and Right Ventricular Failure: A Possible Novel Therapeutic Target.
    Omura J; Satoh K; Kikuchi N; Satoh T; Kurosawa R; Nogi M; Ohtsuki T; Al-Mamun ME; Siddique MAH; Yaoita N; Sunamura S; Miyata S; Hoshikawa Y; Okada Y; Shimokawa H
    Circ Res; 2019 Oct; 125(10):884-906. PubMed ID: 31556812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
    Liu H; Zhang S; Liu Y; Ma J; Chen W; Yin T; Li T; Liang B; Tao L
    Respir Res; 2022 Aug; 23(1):209. PubMed ID: 35986277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of calcium-sensing receptors in hypoxia-induced vascular remodeling and pulmonary hypertension by promoting phenotypic modulation of small pulmonary arteries.
    Peng X; Li HX; Shao HJ; Li GW; Sun J; Xi YH; Li HZ; Wang XY; Wang LN; Bai SZ; Zhang WH; Zhang L; Yang GD; Wu LY; Wang R; Xu CQ
    Mol Cell Biochem; 2014 Nov; 396(1-2):87-98. PubMed ID: 25063217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. eIF2α promotes vascular remodeling via autophagy in monocrotaline-induced pulmonary arterial hypertension rats.
    Guo L; Li Y; Tian Y; Gong S; Chen X; Peng T; Wang A; Jiang Z
    Drug Des Devel Ther; 2019; 13():2799-2809. PubMed ID: 31496656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTRP9 regulates hypoxia-mediated human pulmonary artery smooth muscle cell proliferation, apoptosis and migration via TGF-β1/ERK1/2 signaling pathway.
    Li YX; Run L; Shi T; Zhang YJ
    Biochem Biophys Res Commun; 2017 Sep; 490(4):1319-1325. PubMed ID: 28688765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of JAK2 protects mice against hypoxia-induced pulmonary arterial hypertension by repressing pulmonary arterial smooth muscle cell proliferation.
    Zhang L; Wang Y; Wu G; Rao L; Wei Y; Yue H; Yuan T; Yang P; Xiong F; Zhang S; Zhou Q; Chen Z; Li J; Mo BW; Zhang H; Xiong W; Wang CY
    Cell Prolif; 2020 Feb; 53(2):e12742. PubMed ID: 31943454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidized DNA Precursors Cleanup by NUDT1 Contributes to Vascular Remodeling in Pulmonary Arterial Hypertension.
    Vitry G; Paulin R; Grobs Y; Lampron MC; Shimauchi T; Lemay SE; Tremblay E; Habbout K; Awada C; Bourgeois A; Nadeau V; Paradis R; Breuils-Bonnet S; Roux-Dalvai F; Orcholski M; Potus F; Provencher S; Boucherat O; Bonnet S
    Am J Respir Crit Care Med; 2021 Mar; 203(5):614-627. PubMed ID: 33021405
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
    Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
    Chi PL; Cheng CC; Hung CC; Wang MT; Liu HY; Ke MW; Shen MC; Lin KC; Kuo SH; Hsieh PP; Wann SR; Huang WC
    Int J Biol Sci; 2022; 18(1):331-348. PubMed ID: 34975336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.